NewLink Genetics to Participate in the Cantor Global Healthcare Conference
A live webcast of the presentation will be available on the Company’s website at www.newlinkgenetics.com in the “Investors & Media” section under “Events and Presentations.” An archived edition of the presentation will be available on NewLink Genetics’ website later that day.
About NewLink Genetics Corporation
NewLink Genetics is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer.
Investor Contact:
Director of Investor Relations
515-598-2555
lmiller@linkp.com
Media Contact:
VP,
LaVoieHealthScience
617-374-8800, ext. 105
scorreia@lavoiehealthscience.com
Source: NewLink Genetics Corporation